Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma.

J De Castro; A Lorenzo; S Morales; J Belón; J Dorta; J Lizón; C Madroñal; P M Gallurt; E Casado; J Feliu

doi:10.1007/s00280-004-0869-z

Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma.

Identifier:nobleid.org/w1/20260515/CE8BA7EB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CE8BA7EB.svg?ark=w1%2F20260515%2FCE8BA7EB)](https://nobleid.org/work/w1/20260515/CE8BA7EB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma.

Identifier:nobleid.org/w1/20260515/CE8BA7EB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CE8BA7EB.svg?ark=w1%2F20260515%2FCE8BA7EB)](https://nobleid.org/work/w1/20260515/CE8BA7EB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work